Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $7.04 up 1.15% from its previous closing price of $6.96. In other words, the price has increased by $1.15 from its previous closing price. On the day, 1.05 million shares were traded. DNA stock price reached its highest trading level at $7.4073 during the session, while it also had its lowest trading level at $7.01.
Ratios:
For a deeper understanding of Ginkgo Bioworks Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.62 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.61.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 02 ’25 when Che Austin bought 99 shares for $7.15 per share.
Che Austin bought 99 shares of DNA for $740 on May 01 ’25. On Apr 30 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $7.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 409365440 and an Enterprise Value of 288920128. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71 while its Price-to-Book (P/B) ratio in mrq is 0.51. Its current Enterprise Value per Revenue stands at 1.273 whereas that against EBITDA is -0.695.
Stock Price History:
The Beta on a monthly basis for DNA is 1.29, which has changed by -0.82186234 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $41.20, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is -5.60%, while the 200-Day Moving Average is calculated to be -22.71%.
Shares Statistics:
For the past three months, DNA has traded an average of 1.67M shares per day and 1055760 over the past ten days. A total of 42.70M shares are outstanding, with a floating share count of 36.98M. Insiders hold about 32.81% of the company’s shares, while institutions hold 59.16% stake in the company. Shares short for DNA as of 1744675200 were 13339269 with a Short Ratio of 8.01, compared to 1741910400 on 9976616. Therefore, it implies a Short% of Shares Outstanding of 13339269 and a Short% of Float of 29.81.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
